<DOC>
	<DOCNO>NCT03072446</DOCNO>
	<brief_summary>The purpose post-market study evaluate UFE agent treatment symptomatic uterine fibroid , use Gel-Bead compare four commonly use embolic agent .</brief_summary>
	<brief_title>Uterine Fibroid Embolization ( UFE ) Symptomatic Fibroids : Comparison Gel-Bead Commonly Used Embolic Agents .</brief_title>
	<detailed_description>This single-center , prospective study conduct one site United Kingdom . Up 30 subject enrol treat Gel-Bead . Prospectively . Enrolled Gel-Bead subject follow 1-month 3-months post-procedure . Data subject treat Gel-Bead compare data previously unpublished , widely present , 100-patient cohort study University Hospital Southampton . This study evaluate 20 subject five different treatment group treatment symptomatic uterine fibroid . The five treatment group include gelatin foam slurry , Embospheres , polyvinyl alcohol ( PVA ) , Bead Block Embozenes .</detailed_description>
	<mesh_term>Leiomyoma</mesh_term>
	<mesh_term>Myofibroma</mesh_term>
	<criteria>1 . Female , age 18 year old 2 . Symptomatic uterine fibroid ( ) require treatment per investigator assessment 3 . Negative serum pregnancy test Baseline visit practice effective contraception study 4 . Willing provide write informed consent prior initiation study procedures 5 . Willing comply specify study assessment followup requirement 1 . Known hypersensitivity porcine product intravascular contrast material 2 . Vascular anatomy blood flow preclude correct catheter placement embolic injection 3 . Presence collateral vessel pathway potentially endanger normal territory embolization</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Uterine Fibroid</keyword>
	<keyword>Embolization</keyword>
	<keyword>symptom</keyword>
	<keyword>Gel-Beads</keyword>
</DOC>